Enjoying our latest content?
Log in or create an account to continue
- Access the most recent journalism from Nature's award-winning team
- Explore the latest features & opinion covering groundbreaking research
or
References
Loscalzo, J. The NIH budget and the future of biomedical research. N. Engl. J. Med. 354, 1665–1667 (2006).
DiMasi, J. A., Hansen, R. W. & Grabowski, H. G. The price of innovation: new estimates of drug development costs. J. Health Econ. 22, 151–185 (2003).
Sewing, A. et al. Helping science to succeed: improving processes in R&D. Drug Discov. Today 13, 227–233 (2008).
Gagnon, M. A. & Lexchin, J. The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States. PLoS Med. 5, e1 (2008).
Donohue, J.M., Cevasco, M. & Rosenthal, M. B. A decade of direct-to-consumer advertising of prescription drugs. N. Engl. J. Med. 357, 673–681 (2007).
Wharton Research Data Services (WRDS) [online], (2009).
Lev, B. Intangibles: Management, Measurement, and Reporting (Brookings Institution Press, Washington D.C., 2001).
Chan, L.K.C., Lakonishok, J. & Sougiannis, T. The stock market valuation of research and development expenditures. J. Finance LVI(6), 2431–2456 (2001).
Bebchuk, L .A. & Fried, J. M. Pay Without Performance (Harvard University Press, Massachusetts, 2006).
Kothari, S.P., Laguerre, T.E. & Leone, A.J. Capitalization versus expensing: evidence on the uncertainty of future earnings from capital expenditures versus R&D outlays. Rev. Account Stud. 7, 355–382 (2002).
Lev, B. & Sougiannis, T. The capitalization, amortization and value-relevance of R&D. J. Account Econ. 21, 107–138 (1996).
Cuatrecasas, P. Drug discovery in jeopardy. J. Clin. Invest. 116, 2837–2842 (2006).
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Supplementary information S1 (box)
Basis of analysis (PDF 787 kb)
Rights and permissions
About this article
Cite this article
Weiss, D., Naik, P. & Weiss, R. The 'big pharma' dilemma: develop new drugs or promote existing ones?. Nat Rev Drug Discov 8, 533–534 (2009). https://doi.org/10.1038/nrd2923
Published:
Issue date:
DOI: https://doi.org/10.1038/nrd2923
This article is cited by
-
Pension and state funds dominating biomedical R&D investment: fiduciary duty and public health
Globalization and Health (2019)
